Emodin Suppresses Maintenance of Stemness by Augmenting Proteosomal Degradation of Epidermal Growth Factor Receptor/Epidermal Growth Factor Receptor Variant III in Glioma Stem Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jeongyub | - |
dc.contributor.author | Lee, Jong-Seon | - |
dc.contributor.author | Jung, Jieun | - |
dc.contributor.author | Lim, Inhye | - |
dc.contributor.author | Lee, Ji-Yun | - |
dc.contributor.author | Park, Myung-Jin | - |
dc.date.accessioned | 2021-09-04T19:28:05Z | - |
dc.date.available | 2021-09-04T19:28:05Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-02-01 | - |
dc.identifier.issn | 1547-3287 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94444 | - |
dc.description.abstract | There is a growing body of evidence that small subpopulations of cells with stem cell-like characteristics within most solid tumors are responsible for the malignancy of aggressive cancer cells and that targeting these cells might be a good therapeutic strategy to reduce the risk of tumor relapse after therapy. Here, we examined the effects of emodin (1,3,8-trihydroxy-6-methylanthraquinone), an active component of the root and rhizome of Rheum palmatum that has several biological activities, including antitumor effects, on primary cultured glioma stem cells (GSCs). Emodin inhibited the self-renewal activity of GSCs in vitro as evidenced by neurosphere formation, limiting dilution, and soft agar clonogenic assays. Emodin inhibited the maintenance of stemness by suppressing the expression of Notch intracellular domain, nonphosphorylated beta-catenin, and phosphorylated STAT3 proteins. In addition, treatment with emodin partially induced apoptosis, reduced cell invasiveness, and sensitized GSCs to ionizing radiation. Intriguingly, emodin induced proteosomal degradation of epidermal growth factor receptor (EGFR)/EGFR variant III (EGFRvIII) by interfering with the association of EGFR/EGFRvIII with heat shock protein 90, resulting in the suppression of stemness pathways. Based on these data, we propose that emodin could be considered as a potent therapeutic adjuvant that targets GSCs. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MARY ANN LIEBERT, INC | - |
dc.subject | COLON-CANCER CELLS | - |
dc.subject | SIGNALING PATHWAY | - |
dc.subject | HSP90 | - |
dc.subject | GLIOBLASTOMA | - |
dc.subject | APOPTOSIS | - |
dc.subject | RADIORESISTANCE | - |
dc.subject | ACTIVATION | - |
dc.subject | KINASE | - |
dc.subject | RESISTANCE | - |
dc.subject | CURCUMIN | - |
dc.title | Emodin Suppresses Maintenance of Stemness by Augmenting Proteosomal Degradation of Epidermal Growth Factor Receptor/Epidermal Growth Factor Receptor Variant III in Glioma Stem Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Ji-Yun | - |
dc.identifier.doi | 10.1089/scd.2014.0210 | - |
dc.identifier.scopusid | 2-s2.0-84921467707 | - |
dc.identifier.wosid | 000348509100002 | - |
dc.identifier.bibliographicCitation | STEM CELLS AND DEVELOPMENT, v.24, no.3, pp.284 - 295 | - |
dc.relation.isPartOf | STEM CELLS AND DEVELOPMENT | - |
dc.citation.title | STEM CELLS AND DEVELOPMENT | - |
dc.citation.volume | 24 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 284 | - |
dc.citation.endPage | 295 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.subject.keywordPlus | COLON-CANCER CELLS | - |
dc.subject.keywordPlus | SIGNALING PATHWAY | - |
dc.subject.keywordPlus | HSP90 | - |
dc.subject.keywordPlus | GLIOBLASTOMA | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | RADIORESISTANCE | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | CURCUMIN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.